Trifluridine

CAS 4682-36-4brhrbrAntihistaminic

CAS 341-69-5brhrbrAntihistaminic

Anti-Fibrotic

CAS 156-51-4brhrbrAntidepressant

CAS 34183-22-7brhrbrAntiarrhythmic

CAS 101-26-8brhrbrCholinergic

Overactive Bladder

Lambert-Eaton Myasthenic Syndrome

Hyperammonaemia

Anti-Parkinson

Opioid use disorder

Acute myeloid leukemia
Myelodysplastic syndrome

After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October 2023. In this series of interviews, we speak to the people and teams behind the award-winning projects, concepts, technologies, and in this case, the CEOs that make a difference. 

We are extremely proud and happy with this CPhI Edition, not only from business point of view, but also for the recognition received at the CPhI Pharma Awards. Enthusiasm, insightful conversations, and shared passion are the keyword for this CPhI Barcelona, and we can't thank you enough for your support.